Study #PA15-0315
EVALUATION OF EFFICACY & IMMUNE-RELATED ADVERSE EVENTS AND PATIENT-REPORTED SYMPTOMS ASSOCIATED WITH IMMUNOTHERAPIES: MD ANDERSON CANCER CENTER EFFORTS FOR ADVANCED MECHANISTIC, CLINICAL, AND TRANSLATIONAL SCIENCE
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Toxicity in Immunotherapy
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Aung Naing
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-888-597-3084
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.